scispace - formally typeset
J

Jesse R. Dixon

Researcher at Salk Institute for Biological Studies

Publications -  55
Citations -  19302

Jesse R. Dixon is an academic researcher from Salk Institute for Biological Studies. The author has contributed to research in topics: Chromatin & Genome. The author has an hindex of 23, co-authored 45 publications receiving 15663 citations. Previous affiliations of Jesse R. Dixon include Howard Hughes Medical Institute & University of California, San Diego.

Papers
More filters
Journal ArticleDOI

Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer

Victoria T. Le, +1326 more
- 21 Mar 2023 - 
Posted ContentDOI

Comparing 3D genome organization in multiple species using Phylo-HMRF

TL;DR: Zhang et al. as discussed by the authors developed a new probabilistic model, named phylogenetic hidden Markov random field (Phylo-HMRF), to identify evolutionary patterns of 3D genome structures based on multi-species Hi-C data by jointly utilizing spatial constraints among genomic loci and continuous-trait evolutionary models.
Posted ContentDOI

Foxp3 Orchestrates Reorganization of Chromatin Architecture to Establish Regulatory T Cell Identity

TL;DR: In this article , the authors comprehensively mapped 3D chromatin organization during Treg cell differentiation, and showed that Treg-specific chromatin structures were progressively established during its lineage specification, and highly associated with Treg signature gene expression.
Posted ContentDOI

Deciphering the Evolutionary History of Complex Rearrangements in Head and Neck Cancer Patients Using Multi-Omic Approach

TL;DR: The findings of the proof-of-principle study that investigated the evolutionary history of complex rearrangements in primary head and neck tumor genomes integrating long-read whole-genome, Hi-C, and RNA sequencing highlight the need for multi-modal sequencing strategies to increase the understanding of cancer evolution and rare biomarkers in poorly understood cancers.